Nadofaragene firadenovec, sold under the brand name adstiladrin, is a gene therapy for the treatment of bladder cancer It delivers the gene encoding human. Includes adstiladrin side effects, interactions and indications.
It delivers a copy of the gene encoding ifnα2b to the bladder urothelium resulting in local expression of the ifnα2b protein for anti. This medicine is to be used only by or under the direct supervision of a doctor. It is a recombinant adenovirus serotype 5 vector containing a.
